173 related articles for article (PubMed ID: 34194545)
1. Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation.
Liu W; Wang K; Xiao YL; Liu C; Gao W; Li DH
Exp Ther Med; 2021 Aug; 22(2):867. PubMed ID: 34194545
[TBL] [Abstract][Full Text] [Related]
2. Preformed donor-specific antibodies are associated with 90-day mortality in living-donor liver transplantation.
Tamura K; Tohyama T; Watanabe J; Nakamura T; Ueno Y; Inoue H; Honjo M; Sakamoto K; Takai A; Ogawa K; Takada Y
Hepatol Res; 2019 Aug; 49(8):929-941. PubMed ID: 30991451
[TBL] [Abstract][Full Text] [Related]
3. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
Kincaide E; Hitchman K; Hall R; Yamaguchi I; Ding Y; Crowther B
Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
Demirok A; Ranzijn C; Lardy J; Florquin S; Bouts A
Pediatr Transplant; 2019 Mar; 23(2):e13338. PubMed ID: 30635959
[TBL] [Abstract][Full Text] [Related]
5. The fate of anti-HLA antibodies following liver transplantation.
Norman DJ; Enestvedt CK; Naugler WE; Erhan R; Shaut CA
Front Nephrol; 2024; 4():1403096. PubMed ID: 38933742
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
Vo AA; Aubert O; Haas M; Huang E; Zhang X; Choi J; Peng A; Najjar R; Sethi S; Ammerman N; Lim K; Jordan SC
Transplantation; 2019 Dec; 103(12):2666-2674. PubMed ID: 30883456
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
9. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.
Roux A; Bendib Le Lan I; Holifanjaniaina S; Thomas KA; Picard C; Grenet D; De Miranda S; Douvry B; Beaumont-Azuar L; Sage E; Devaquet J; Cuquemelle E; Le Guen M; Suberbielle C; Gautreau C; Stern M; Rossetti M; Hamid AM; Parquin F
Front Med (Lausanne); 2017; 4():155. PubMed ID: 29075627
[TBL] [Abstract][Full Text] [Related]
11. Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients.
Song SH; Kim MS; Lee JJ; Ju MK; Lee JG; Lee J; Choi JS; Choi GH; Kim SI; Joo DJ
Ann Surg Treat Res; 2015 Feb; 88(2):100-5. PubMed ID: 25692121
[TBL] [Abstract][Full Text] [Related]
12. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and predictive value for graft fibrosis of the complement-binding capacity of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation.
Tokodai K; Miyagi S; Nakanishi W; Nishimura R; Fujio A; Goto M; Unno M; Kamei T
Pediatr Transplant; 2020 Feb; 24(1):e13648. PubMed ID: 31885148
[TBL] [Abstract][Full Text] [Related]
14. Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation.
Schotters FL; Beime J; Briem-Richter A; Binder T; Herden U; Grabhorn EF
World J Hepatol; 2021 Jun; 13(6):673-685. PubMed ID: 34239702
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
16. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
18. [Relationship of distribution frequency of HLA antigen/antibody and PIRCHE score with DSA production and AMR occurrence].
Zheng J; Kuang PD; Zhang Y; Zhao Q; He XL; Ding XM; Xue WJ
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):901-906. PubMed ID: 30917438
[No Abstract] [Full Text] [Related]
19. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
20. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]